Drugs Online |
 |
 | ||
|
Hansepran Lamprene |
|
| ||
Drugs Online » Prescription Drugs 8 » Hansepran Lamprene Clofazimine is an antibiotic which attacks the bacteria that cause leprosy by an unknown mechanism. It is thought to interfere with the production of genetic material (DNA) in the bacteria. Clofazimine also has an anti-inflammatory action to reduce the swelling and pain associated with leprosy.Clofazimine is used in combination with other medications and therapy should be continued for at least two years. Buy Hansepran Lamprene and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About Hansepran Lamprene: Product Type: Prescription Drugs 8 Hansepran ( Lamprene Generic Clofazimine ) Hansepran (Lamprene Generic Clofazimine) Lamprene Generic Clofazimine 100mg 2 x 100 Tablets 100mg 4 x 100 Tablets 100mg 100 Tablets 50mg 100 Tablets 50mg 4 x 100 Tablets 50mg 2 x 100 Tablets Lamprene Generic Clofazimine Hansepran
View more Prescription Drugs 8 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
